Efficacy of the treatment with interferon, ribavirin and amantadine, in patients with hepatitis C non-responders or relapsers to the conventional therapy.

被引：0
|
作者：
Carmen, SE [1 ]
机构：
[1] Hosp Puerta Hierro, Madrid, Spain
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1701
引用
收藏
页码：588A / 588A
页数：1
相关论文
共 50 条
  • [31] Interferon-gamma with interferon-alpha and ribavirin for hepatitis C non-responders
    Raza, S.
    Abbas, Z.
    Jafri, W.
    Hameed, S.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 : 44 - 44
  • [32] High-dose interferon alfacon-1 is a treatment option for non-responders and relapsers to combined therapy with interferon and ribavirin.
    Sjogren, MH
    Wu, G
    Herrine, SK
    Raufman, JP
    Bacon, BR
    Epstein, M
    Medoff, J
    Chen, S
    Waters, B
    Krawitt, E
    Sjogren, RW
    Herrera, J
    HEPATOLOGY, 2000, 32 (04) : 352A - 352A
  • [33] Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy:: a randomized trial
    Salmeron, J.
    Diago, M.
    Andrade, R.
    Perez, R.
    Sola, R.
    Romero, M.
    de la Mata, M.
    Granados, R.
    Ruiz-Extremera, A.
    Munoz de Rueda, P.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (02) : 89 - 95
  • [34] Efficacy of pegylated interferon alpha-2b in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment
    Chousterman, M
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    JOURNAL OF HEPATOLOGY, 2003, 38 : 133 - 134
  • [35] Retreatment of chronic hepatitis C in previous non-responders and relapsers
    Satoskar, Rohit
    Jensen, Donald M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (15) : 2491 - 2503
  • [36] Tolerance to pegylated interferon maintenance therapy in patients with chronic hepatitis C who are non-responders to standard combination therapy.
    Selim, K
    Behling, C
    Lyche, KD
    Winston, DH
    Rossi, SJ
    Wahlstrom, EH
    Hyun, CB
    Jensen, JE
    Babich, MM
    Nguyen, TT
    Stewart, MA
    Myers, WY
    Ziegler, EA
    Oliver, DL
    Hassanein, TI
    HEPATOLOGY, 2002, 36 (04) : 574A - 574A
  • [37] Efficacy of interferon plus ribavirin in chronic hepatitis C patients non responders to interferon alone
    Picciotto, A
    Campo, N
    Torre, F
    Brizzolara, R
    Sinelli, N
    Celle, G
    HEPATOLOGY, 1998, 28 (04) : 479A - 479A
  • [38] Early Virological Response with Consensus Interferon and Ribavirin in HCV Genotype 3 Non-Responders and Relapsers to Pegylated Interferon Based Therapy
    Shakir, Tanzila
    Abbas, Zaigham
    Memon, Sadik
    Tayyab, Ghias
    Shaikh, Kashif
    Nasir, Bilal
    Hassan, Ghias
    Subhan, Amna
    Hamid, Saeed
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S122 - S123
  • [39] A controlled study of amantadine monotherapy vs. amantadine combined with interferon-α in chronic hepatitis C patients non-responders to interferon-α.
    El-Zayadi, A
    Selim, O
    Shawky, S
    Moustafa, H
    El-Taweel, A
    HEPATOLOGY, 1998, 28 (04) : 473A - 473A
  • [40] Combination of interferon induction therapy and ribavirin in primary interferon non-responders infected with genotype 1 hepatitis C virus
    Erdem, L
    Akbayir, N
    Cakaloglu, Y
    Cevikbas, U
    Badur, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 234 - 234
12345